Target enzyme activity and phosphorylation of pathway molecules As specific biomarkers in transplantation

Abstract:Therapeutic drug monitoring of immunosuppressants in the clinic is based on the measurement of blood concentration (pharmacokinetics). However, pharmacokinetic monitoring of immunosuppressants does not allow prediction of individual differences in pharmacological effects on immune cells. Ph

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Budde, Klemens (VerfasserIn) , Sommerer, Claudia (VerfasserIn) , Rissling, Olesja (VerfasserIn) , Dieterlen, Maja-Theresa (VerfasserIn) , Barten, Markus Johannes (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: April 2016
In: Therapeutic drug monitoring
Year: 2016, Jahrgang: 38, Pages: S43–S49
ISSN:1536-3694
DOI:10.1097/FTD.0000000000000288
Online-Zugang:Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1097/FTD.0000000000000288
Volltext
Verfasserangaben:Klemens Budde, Claudia Sommerer, Olesja Rissling, Maja Dieterlen, Markus Barten
Beschreibung
Zusammenfassung:Abstract:Therapeutic drug monitoring of immunosuppressants in the clinic is based on the measurement of blood concentration (pharmacokinetics). However, pharmacokinetic monitoring of immunosuppressants does not allow prediction of individual differences in pharmacological effects on immune cells. Ph
Beschreibung:Gesehen am 20.05.2020
Beschreibung:Online Resource
ISSN:1536-3694
DOI:10.1097/FTD.0000000000000288